| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/16/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
| 10/07/2022 | 400% | Morgan Stanley | → $7.5 | Initiates Coverage On | → Equal-Weight |
| 09/29/2022 | 366.67% | B of A Securities | → $7 | Initiates Coverage On | → Buy |
| 09/23/2022 | 700% | Chardan Capital | → $12 | Initiates Coverage On | → Buy |
What is the target price for Senti Biosciences (SNTI)?
The latest price target for Senti Biosciences (NASDAQ: SNTI) was reported by JP Morgan on December 16, 2022. The analyst firm set a price target for $0.00 expecting SNTI to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Senti Biosciences (SNTI)?
The latest analyst rating for Senti Biosciences (NASDAQ: SNTI) was provided by JP Morgan, and Senti Biosciences initiated their neutral rating.
When is the next analyst rating going to be posted or updated for Senti Biosciences (SNTI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Senti Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Senti Biosciences was filed on December 16, 2022 so you should expect the next rating to be made available sometime around December 16, 2023.
Is the Analyst Rating Senti Biosciences (SNTI) correct?
While ratings are subjective and will change, the latest Senti Biosciences (SNTI) rating was a initiated with a price target of $0.00 to $0.00. The current price Senti Biosciences (SNTI) is trading at is $1.50, which is out of the analyst's predicted range.